Company intelligence / Profile preview

Wave Therapeutics

Nashville, Indiana, United States

Ownership: Private
Development stage: Other

Overview

The company has developed and is launching a patented cushion aimed at reducing risk of pressure injuries and blood clots for wheelchair users. Combines alternating pressure and sequential compression therapies via unique microprocessor technology, with embedded sensors for real-time patient monitoring. Aims to launch at ~$600 retail and via subscription.

Therapeutic areas: CardiovascularDermatology
Modalities: Device (Smart Cushioning Technology)
Industry: Therapeutic Medical Devices

Partnerships

Collaborations with engineering schools (academic partnerships/internships)

Beyond the preview

Go deeper on Wave Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wave Therapeutics.

Explore the full profile